Hosted on MSN1d
Wall Street Analysts Predict a 25.59% Upside in BioNTech (BNTX): Here's What You Should Know
BioNTech SE Sponsored ADR (BNTX) closed the last trading session at $112.76, gaining 1.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets ...
Reuters22d
BioNTech enters settlement with US agency, UPenn over COVID vaccine royalties
Dec 27 (Reuters) - BioNTech (22UAy.DE), opens new tab has entered into two separate settlement agreements with the U.S. National Institutes of Health and the University of Pennsylvania over the ...
BioNTech Positioned For Solid Growth Amid Oncology Transition: Analyst
Truist initiated coverage on BioNTech SE (NASDAQ:BNTX), a famed COVID-19 vaccine maker, in collaboration with Pfizer Inc ...
pharmaphorum8d
Pfizer, BioNTech submit to FDA for Covid vaccine in under 5s
Pfizer and BioNTech have announced that they have submitted an Emergency Use Authorisation (EUA) to the US Food and Drug Administration (FDA) for their Omicron BA.4/BA.5-adapted bivalent COVID-19 ...
Yahoo Finance22d
BioNTech and Pfizer to pay Covid-19 vaccine settlements in US
BioNTech and its partner US pharmaceutical giant Pfizer are to pay a total of a €1.2 billion ($1.3 billion) to the US health agency and the University of Pennsylvania, BioNTech said. The ...
Nasdaq22d
BioNTech Enters Into Settlements With U.S. Agency, UPenn Over COVID-19 Vaccine Royalties
(RTTNews) - BioNTech SE (BNTX), Friday reached two separate settlements with the U.S. National Institutes of Health, and the University of Pennsylvania regarding the royalties payment of COVID-19 ...
Bank of America Securities Keeps Their Buy Rating on BioNTech SE (BNTX)
Bank of America Securities analyst Tazeen Ahmad maintained a Buy rating on BioNTech SE (BNTX – Research Report) yesterday and set a price ...
No, WHO did not 'admit' COVID-19 vaccines cause mpox | Fact check
In the database, there are reports of individuals contracting mpox at some point after receiving the Pfizer-BioNTech COVID-19 ... vaccines cannot cause mpox, as USA TODAY previously reported.
The Motley Fool8d
BioNTech Se (NASDAQ: BNTX)
BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T ...
Morningstar8d
BioNTech SE ADR BNTX
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Benzinga.com8d
BioNTech Positioned For Solid Growth Amid Oncology Transition: Analyst
Truist sets BioNTech's price target at $172, highlighting BNT327's revenue potential of $6B+ across multiple cancer indications. BioNTech's BNT327 could lead U.S. and European approvals for key ...